wire

Aspirin is an inexpensive and readily available medication that could benefit cancer treatments, preventing metastatic cancer spread and reducing vascular complications, finds new meta-analysis study. The Welsh Aspirin Group in Cardiff University has published a systematic review and meta-analysis examining the impacts of the use of aspirin as a treatment for cancer.

Reducing oxygen levels in critically ill children on mechanical ventilators in intensive care could save tens of young lives each year, finds a new study led by researchers at UCL and Great Ormond Street Hospital.

Change in clinical practice would have clear benefits for patients undergoing major bowel surgery, according to analysis conducted by researchers from UCL and the Royal Devon and Exeter Hospital. The study, published in The British Journal of Surgery , provides evidence that giving iron intravenously before colorectal surgery improves outcomes for patients, reducing the need for blood transfusion by 33%.

UK becomes the first country to approve CRISPR gene therapy treatment for two inherited blood disorders.

An AI tool that can predict 10-year risk of deadly heart attacks, could transform treatment for patients who undergo CT scans to investigate chest pain, according to British Heart Foundation-funded research presented today at the American Heart Association's Scientific Sessions in Philadelphia.

A major new trial has been launched which could transform outcomes for patients with bladder cancer by matching treatments to genetic Current standard treatments for patients with cancer of the bladder wall involve chemotherapy, before either surgery to remove the bladder or radiotherapy. Until now, it has not been possible to say how individuals will respond to this treatment.

GP clinics in London and Wales will receive an AI-powered tool as part of a trial to help improve the diagnosis of a deadly heart condition.

The RECOVERY trial , which discovered four effective treatments for COVID-19, has expanded to investigate treatments for influenza (flu). Globally, seasonal flu epidemics are estimated to kill between 290,000 and 650,000 people every year. Despite having known about influenza for almost a century and knowing that pandemic influenza remains one of the greatest threats to human health, we still do not have effective drugs for treating people with severe influenza.

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial. The findings, published in  Ophthalmology , describe the efficacy and safety of the first drug candidate for the treatment of Acanthamoeba keratitis (AK), applying a novel and evidence-based treatment protocol.

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

A new national trial will aim to determine the most effective breathing support for babies hospitalised with bronchiolitis.

An affordable microneedle skin patch that delivers a controlled dose of medicine directly into the body has been developed by a team led by scientists at Bath.

Published: 12 October 2023 The PancAim project, which aims to use artificial intelligence (AI) to improve Pancreatic Cancer treatment, will soon realise the broad implementation of a novel AI algorithm for earlier detection of the disease on CT.

The charity has awarded £249,992 to Dr Sankari Nagarajan and her team at the University of Manchester to help discover why some triple negative breast cancers spread to other parts of the body and whether existing drugs can be repurposed to stop this from happening. Around 15%* of breast cancers are classed as triple negative and if this form of the disease becomes resistant to chemotherapy, there are few other treatments available.

Researchers are partners in a UK initiative to improve clinical imaging for research and the development of new treatments.

Scotland is set to receive its first total-body scanner in a boost to clinical research that aims to improve the detection, diagnosis and treatment of complex, multi-organ diseases Scotland is set to receive its first total-body scanner in a boost to clinical research that aims to improve the detection, diagnosis and treatment of complex, multi-organ diseases.

1920_stock-photo-grocery-shopping-as-a-delivery-service-for-quarantined-seniors-at-the-covid-coronavirus-epidemic-1692080692 People who shielded during the Covid pandemic say they have been treated like "second class citizens" whose needs have been ignored.

The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax's adjuvant is critical to reducing over half a million malaria-related deaths annually.

New funding will help Cardiff researchers further potential treatments for prostate cancer, through the first drug to target the BLC3 cell signalling pathway.

The University of Glasgow and Keele University have received a prestigious million-pound grant from the Medical Research Council to improve our understanding of a rare developmental disorder.

First empirical evidence for Civica Rx, a health care utility, finds increased supply security and reduced costs for health systems, says study in NEJM Catalyst authored by two Cambridge Judge Business School academics.

Mindfulness practices such as meditation and yoga should be recommended to people with high blood pressure, according to a comprehensive review of lifestyle changes that can help prevent and manage the condition, co-authored by UCL's Professor Bryan Williams.

Research from academics at Bath and Lund, Sweden, urges healthcare professionals to tackle unethical marketing and support stronger regulation.

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched last week (Friday 15 September 2023).  This is the third Phase I clinical trial of th

The Christie NHS Foundation Trust and The University of Manchester have been awarded half a million pounds of funding from the Medical Research Council to produce a new immunotherapy for oesophageal cancer patients.

AlveoGene will work on gene therapies for several rare lung conditions, beginning with alpha-1 antitrypsin deficiency.

A pioneering programme which is bringing affordable, reliable and portable diagnostics for multiple diseases to sub-Saharan Africa is set to be presented at an event linked to the United Nations General Assembly this week.

An Imperial surgeon specialising in the gut microbiome has published a new book to explain why it is important for our health. Consultant surgeon, Dr James Kinross , is Senior Lecturer in Colorectal Surgery in the Department of Surgery & Cancer at Imperial College London. He is also a consultant surgeon at Imperial College Healthcare NHS Trust.

A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.

Early surgery for isolated cleft palate repair is more likely to achieve a successful outcome, according to an international study of newborn babies from across Europe and South America. The study was led by Professor William Shaw on behalf of the University of Manchester and Professor Carrol Gamble on behalf of the University of Liverpool, along with senior co-investigators from the Universities Gothenburg, Copenhagen, São Paulo, and Edinburgh.

Underfunding in reproductive health research, exclusion from clinical trials and misinformation mean women are being underserved by medical science.

A major Cancer Research UK clinical trial aiming to find effective new treatments for patients with rare forms of the disease has launched in Scotland.